View from Brussels

Peter O'Donnell is a freelance journalist who specializes in European health affairs and is based in Brussels, Belgium.

Articles

Allegedly more than 4,000 clinical trials of medicines are missing results on the European trial registry, in violation of transparency rules. 

A new report from the EMA and EUnetHTA shows a shift towards a more efficient form of collaboration.

Conclusions from the Global Health Summit provide plenty of support for research, innovation, investment, and incentivization.

A major international collaboration within ICH features big hitters from across the world's major regulatory authorities and drug firms

Pressure mounts in Brussels as calls for new ways to debate pharma policies come from all directions.

Parliament's health committee is answering calls for a firmer grip on policies affecting the well-being of its 450 million citizens.

European Group on Ethics in Science and New Technologies issues cautious opinion on the use of gene editing amidst COVID vaccination controversy.

Rate of adoption in Europe for advanced diagnostics is falling behind that of others' globally.

A new partnership, to be known as EP PerMed, aims to bring public and private sector interests together. 

Upcoming study reveals challenges faced by Europe over the pricing of pharmaceuticals.